Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2025-12-29 @ 1:06 PM
Study NCT ID:
NCT00776503
Status:
COMPLETED
Last Update Posted:
2014-03-20
First Post:
2008-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia
Sponsor:
Groupe Francophone des Myelodysplasies
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-05
Start Date Type:
None
Primary Completion Date:
2011-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-11
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-20
First Submit QC Date:
None
Study First Post Date:
2008-10-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-03-19
Last Update Post Date:
2014-03-20
Last Update Post Date Type:
ESTIMATED